Experimental hepatitis B drug might offer ‘functional cure’ for a subset of patients
New research suggests a first-of-its-kind drug for hepatitis B may let some patients stop treatment without showing signs of the dangerous liver virus.
Original Source
Read the full article at Seattletimes →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.